Rectal protection in prostate stereotactic radiotherapy: a retrospective exploratory analysis of two rectal displacement devices-Reference-Cited by-同舟云学术

Rectal protection in prostate stereotactic radiotherapy: a retrospective exploratory analysis of two rectal displacement devices

Published:2017-08-08 Issue:4 Volume:64 Page:266-273
ISSN:2051-3895
Container-title:Journal of Medical Radiation Sciences
language:en
Short-container-title:J Med Radiat Sci

Author:

Wilton Lee¹^ORCID,Richardson Matthew¹,Keats Sarah²,Legge Kimberley³,Hanlon Mary-Claire¹^ORCID,Arumugam Sankar²,Hunter Perry¹,Evans Tiffany-Jane⁴,Sidhom Mark²,Martin Jarad¹⁵

Affiliation:

1. Calvary Mater Newcastle; Waratah New South Wales Australia

2. Liverpool and Macarthur Cancer Therapy Centres; Liverpool New South Wales Australia

3. School of Mathematical and Physical Sciences; University of Newcastle; University Drive; Callaghan New South Wales Australia

4. Clinical Research Design, Information Technology and Statistical Support (CReDITSS); Hunter Medical Research Institute; New Lambton New South Wales Australia

5. School of Medicine and Public Health; Faculty of Health; University of Newcastle; University Drive; Callaghan New South Wales Australia

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference23 articles.

1. Quality of life and satisfaction with outcome among prostate-cancer survivors;Sanda;N Engl J Med,2008

2. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (hypro): Late toxicity results from a randomised, non-inferiority, phase 3 trial;Aluwini;Lancet Oncol,2016

3. Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 chhip trial;Wilkins;Lancet Oncol,2015

4. Randomized phase iii noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer;Lee;J Clin Oncol,2016

5. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 chhip trial;Dearnaley;Lancet Oncol,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre Trial;European Urology Oncology;2024-02

2. Safer and More Convenient Modern Curative Radiotherapy for Patients With Early Prostate Cancer;Anticancer Research;2023-12-30

3. Radiological evaluation of an iodised hydrogel for prostate radiotherapy applications;Physica Medica;2023-10

4. Virtual HDR Boost for Prostate Cancer: Rebooting a Classic Treatment Using Modern Tech;Cancers;2023-03-28

5. Rectal retractor in prostate radiotherapy: pros and cons;Radiation Oncology;2022-12-09